Get the Stockscreener App
14.94
32.56%
3.67
After Hours:
14.93
-0.010
-0.07%
Biodesix Inc stock is traded at $14.94, with a volume of 449.22K.
It is up +32.56% in the last 24 hours and down -0.86% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
See More
Previous Close:
$11.27
Open:
$13.5
24h Volume:
449.22K
Relative Volume:
4.02
Market Cap:
$151.00M
Revenue:
$88.50M
Net Income/Loss:
$-35.27M
P/E Ratio:
-4.5336
EPS:
-3.2954
Net Cash Flow:
$-23.70M
1W Performance:
+50.15%
1M Performance:
-0.86%
6M Performance:
+73.72%
1Y Performance:
+57.50%
1-Day Range:
$13.32
$15.51
1-Week Range:
$9.432
$15.51
52-Week Range:
$3.436
$20.21
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
14.94 | 113.91M | 88.50M | -35.27M | -23.70M | -3.2954 |
TMO
Thermo Fisher Scientific Inc
|
466.76 | 171.91B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.63 | 123.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.97 | 44.73B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
342.75 | 29.63B | 3.17B | 642.63M | 516.49M | 10.77 |
A
Agilent Technologies Inc
|
117.53 | 31.70B | 7.07B | 1.29B | 993.00M | 4.5355 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jul-26-24 | Initiated | Craig Hallum | Buy |
| May-13-24 | Initiated | TD Cowen | Buy |
| May-03-24 | Initiated | Lake Street | Buy |
| Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-20 | Initiated | BTIG Research | Buy |
| Nov-23-20 | Initiated | Canaccord Genuity | Buy |
| Nov-23-20 | Initiated | Morgan Stanley | Overweight |
| Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
Biodesix Earnings Call Signals Strong Growth Momentum - TipRanks
Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price - MarketBeat
Biodesix touts ‘clear path toward profitability’ - BizWest
Biodesix Inc. 10-Q Q1 2026: Financial Statements, Risk Factors, and Management Analysis - Minichart
Biodesix stock price target raised to $22 by Canaccord on revenue growth - Investing.com
Biodesix, Inc. (NASDAQ:BDSX) Q1 2026 Earnings Call Transcript - Insider Monkey
Biodesix, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Biodesix Q1 Earnings Call Highlights - MarketBeat
Biodesix (BDSX) Q1 2026 Earnings Transcript - The Globe and Mail
BDSX: Q1 revenue up 42% year-over-year, with raised 2026 guidance and margin expansion - TradingView
Earnings call transcript: Biodesix Q1 2026 shows revenue growth, stock steady - Investing.com
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Biodesix Inc (NASDAQ:BDSX) Q1 Results Smash Estimates, Shares Jump on Raised Guidance - ChartMill
Biodesix (NASDAQ:BDSX) Announces Earnings Results - MarketBeat
Q1 2026 Biodesix Inc Earnings Call Transcript - GuruFocus
Biodesix Announces First Quarter 2026 Results and Highlights - The Manila Times
Biodesix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Biodesix (NASDAQ: BDSX) grows Q1 2026 revenue and trims loss - Stock Titan
Biodesix lifts 2026 forecast after Q1 revenue hits $25.6M - Stock Titan
Strong Q1 for Biodesix (Nasdaq: BDSX) with 42% revenue growth - Stock Titan
Biodesix Inc expected to post a loss of $1.10 a shareEarnings Preview - TradingView
Earnings To Watch: Biodesix Inc (BDSX) Reports Q1 2026 Result - GuruFocus
Earnings Preview: Biodesix to Report Financial Results Post-market on May 04 - Moomoo
Biodesix (NASDAQ: BDSX) holder AIGH reports 7.7% ownership - Stock Titan
Wall Street analysts think Biodesix (BDSX) could surge 111.62%: Read this before placing a bet - MSN
BDSX Stock Price, Quote & Chart | BIODESIX INC (NASDAQ:BDSX) - ChartMill
Wall Street analysts see an 86.45% upside in Biodesix (BDSX): Can the stock really move this high? - MSN
Biodesix (BDSX) to Release Earnings on Monday - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Biodesix skyrockets 43%, expects FY revenue to beat guidance - MSN
BDSX Price Today: Biodesix, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Are Medical Stocks Lagging Aura Biosciences (AURA) This Year? - Yahoo Finance
BDSX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Biodesix (BDSX) Options Set for Delisting on April 20 - GuruFocus
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026 - 富途牛牛
Biodesix to highlight novel diagnostic test discovery and pipeline development at AACR 2026 - SelectScience
Biodesix plans May 4 Q1 results release, 4:30 p.m. ET webcast - Stock Titan
How Recent Shifts Are Reframing The Biodesix (BDSX) Investment Story - Yahoo Finance
Aberdeen Group plc Takes $1.78 Million Position in Biodesix, Inc. $BDSX - MarketBeat
Biodesix (NASDAQ: BDSX) outlines 2026 virtual meeting, board and pay votes - Stock Titan
Employees put Biodesix on USA TODAY's Top Workplaces list for a third year - Stock Titan
Rate Hike: Can Biodesix Inc expand into new marketsQuarterly Portfolio Report & Accurate Buy Signal Notifications - baoquankhu1.vn
Biodesix, Inc. (BDSX) stock price, news, quote and history - Yahoo Finance UK
Biodesix Unveils Novel Diagnostic Test at AACR 2026 - National Today
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development - The Manila Times
Biodesix to Showcase Advances in Diagnostic Solutions at AACR Annual Meeting 2026 - Quiver Quantitative
Cancer test developer Biodesix brings 7 studies to AACR meeting - Stock Titan
Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year? - qz.com
Energy Moves: Can Biodesix Inc expand into new markets2026 Big Picture & Precise Buy Zone Identification - baoquankhu1.vn
BDSX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):